CENTURY(SZ:300078) Xin Jing Bao·2025-11-19 04:33Core Viewpoint - The control of Sichuang Medical Technology Co., Ltd. is set to change, with Wei Naixu's Cangnan Xinsheng becoming the controlling shareholder, transitioning from no actual controller to Wei Naixu [1][3]. Group 1: Share Transfer Agreement - The largest shareholder, Lu Nan, signed a share transfer agreement with Cangnan Xinsheng to transfer 62,739,500 shares, representing 5.61% of the total share capital, at a price of 2.872 yuan per share, totaling 180 million yuan [2][4]. - Cangnan Xinsheng will also exercise voting rights for an additional 63,890,185 shares held by Cangnan Si Jia Wulian Intelligent Partnership, representing 5.72% of the total share capital [2][3]. Group 2: Background and Previous Attempts - In April, a previous attempt was made to transfer control to Cangnan Industrial Construction Investment Co., Ltd., but this was terminated due to non-compliance with state asset supervision requirements [4]. - The company has been facing financial difficulties, with cumulative losses exceeding 2.9 billion yuan since 2021, and reported a revenue of 604 million yuan with a loss of 4.76 million yuan in the first three quarters of 2025 [4][5]. Group 3: Future Implications - The share transfer and voting rights delegation are subject to compliance review by the Shenzhen Stock Exchange and require approval from the shareholders' meeting, indicating uncertainty in the final implementation [3]. - The involvement of state-owned capital is expected to leverage resources for the long-term stable development of the company [3].